id,group_id,source,exact,prefix,suffix,anno_type,position_type,start,end,tags,all,origin_tags,comment,user,title,created
ztoptq0kEem51SfsCLMs9Q,b53nbDmi,https://europepmc.org/articles/PMC5395742/,p27,"ed by CUL4A including p53, p21, ",", DICER, and LATS1 [32]. Previou",TextQuoteSelector,TextPositionSelector,40579,40582,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:35:20.926896+00:00
zK_A8LQ8Eem_LftIdG12uQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,HCC proliferation and metastasis via the uc.134-CUL4A,protein.LncRNA uc.134 represses ,-Hippo axisA Western blot analys,TextQuoteSelector,TextPositionSelector,46690,46743,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:14:43.290042+00:00
zJB2YK0fEemUCaP02poZTg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,animals,lines for the use of laboratory ,. For the subcutaneously injecte,TextQuoteSelector,TextPositionSelector,21664,21671,CRT_OG,no,CRT_OG,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:59:29.421190+00:00
yzwJEq0mEemafP-NHiTbdw,b53nbDmi,https://europepmc.org/articles/PMC5395742/,genetic disease,h HCC.Cancer is fundamentally a , with numerous alterations in DN,TextQuoteSelector,TextPositionSelector,52964,52979,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:49:33.822531+00:00
yj6R2q0kEemPjJfMKJxfCg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,p21,"tinated by CUL4A including p53, ",", p27, DICER, and LATS1 [32]. Pr",TextQuoteSelector,TextPositionSelector,40574,40577,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:35:13.184204+00:00
xWxzLrQ8EemeBU_J2EN86A,b53nbDmi,https://europepmc.org/articles/PMC5395742/,LATS1 and CUL4A protein in HCC, interaction between endogenous , cells (Fig. 4c). Although a lar,TextQuoteSelector,TextPositionSelector,42398,42428,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:14:31.160609+00:00
xQlXOK0nEemothNkCvriFg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,NF2,o and ubiquitinating LATS1/2 in ,-mutant tumors in the nucleus [3,TextQuoteSelector,TextPositionSelector,55183,55186,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:56:32.957077+00:00
xCJlPq0jEemop_M8Dvzu-g,b53nbDmi,https://europepmc.org/articles/PMC5395742/,RSRC1,ted in the intron region of the , gene (Fig. 1b) exhibited the gr,TextQuoteSelector,TextPositionSelector,29570,29575,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:27:53.411680+00:00
woCbeK0kEemwVSNjjjISdQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,p53,biquitinated by CUL4A including ,", p21, p27, DICER, and LATS1 [32",TextQuoteSelector,TextPositionSelector,40569,40572,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:35:00.299035+00:00
wNlfpLRiEem9NrNJ79IqsA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,serine/threonine kinase,"r therapies [41]. Moreover, the ", LATS1 is a core kinase of Hippo,TextQuoteSelector,TextPositionSelector,54503,54526,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T13:46:24.387903+00:00
vnU23LQ8EemQdZ_zCDZSNA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,tumor model by injecting the indicated cells into the tail veins of nude,generated a tail vein xenograft , mice. At the end of the experim,TextQuoteSelector,TextPositionSelector,36416,36488,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:14:19.322598+00:00
v4PrKK0fEem_yLOsYUFO_Q,b53nbDmi,https://europepmc.org/articles/PMC5395742/,BALB/c nude mice,ittee of Nanfang Hospital. Male ," (age, 4–6 weeks; Guangdong Medi",TextQuoteSelector,TextPositionSelector,21419,21435,WS_OG,no,WS_OG,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:59:07.706730+00:00
uoSQ7q0mEemZlzNsvSjEWw,b53nbDmi,https://europepmc.org/articles/PMC5395742/,mice,"highly conserved across humans, ",", and rats, so-called ultraconse",TextQuoteSelector,TextPositionSelector,51781,51785,CRT_OG,yes,[CRT_OG][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:49:05.882364+00:00
uMRdJq0lEem2mfcLZDrOGA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,Hippo,S1 plays essential roles in the ," pathway, which suppresses tumor",TextQuoteSelector,TextPositionSelector,42492,42497,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:41:53.326290+00:00
uJcnILQ8EemIF9_c-E87_Q,b53nbDmi,https://europepmc.org/articles/PMC5395742/,tumor model by subcutaneously injecting HCC cells in which uc.134 was stably overexpressed or knocked down into the flanks of nude,"udies, we generated a xenograft ", mice. The overexpression of uc.,TextQuoteSelector,TextPositionSelector,35533,35663,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:14:09.522768+00:00
snvqgq0mEem2q5_AUAxeHg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,humans,hat are highly conserved across ,", mice, and rats, so-called ultr",TextQuoteSelector,TextPositionSelector,51773,51779,CRT_OG,no,CRT_OG,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:48:52.458010+00:00
rSoxSq0eEemTyD_2ZonTPg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,kinase,y is a highly conserved protein , chain that plays a pivotal role,TextQuoteSelector,TextPositionSelector,14999,15005,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:51:27.451207+00:00
qqK6Fq0mEemstJNircP7VA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,rats,"served across humans, mice, and ",", so-called ultraconserved regio",TextQuoteSelector,TextPositionSelector,51791,51795,CRT_OG,no,CRT_OG,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:48:39.130813+00:00
qAXchq0fEemPgceg3w9yMg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,animal,ed significant.In vivo modelAll , studies were performed with the,TextQuoteSelector,TextPositionSelector,21292,21298,MIS_OG,no,MIS_OG,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:58:28.328535+00:00
q5gKTrQ8Eem6UKsqv5HDxQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,HCC progression by inhibiting the CUL4A-mediated ubiquitination of LATS1,e novel lncRNA uc.134 represses , and increasing pYAPS127 express,TextQuoteSelector,TextPositionSelector,16689,16761,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:13:47.801924+00:00
pP4bBK0nEem-9kP2c8HXOQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,CRL4, kinase signaling by inhibiting ,"DCAF1, an E3 ubiquitin ligase of",TextQuoteSelector,TextPositionSelector,54717,54721,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:55:39.273090+00:00
p3aw-rQ8EemRQkvRZRf0cQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,HCC cell proliferation and invasion by inhibiting CUL4A to ubiquitinate LATS1,expression of uc.134 suppresses , and increasing pYAPS127 express,TextQuoteSelector,TextPositionSelector,16289,16366,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:13:40.923700+00:00
oO84GrQ8EemIFssB41ZgNQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,hepatocellular carcinoma progression by inhibiting the CUL4A-mediated ubiquitination of LATS1,"novel lncRNA, uc.134, represses ", and increasing YAPS127 phosphor,TextQuoteSelector,TextPositionSelector,12079,12172,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:13:29.941363+00:00
niwz1q0pEem_AKOPVI4m6A,b53nbDmi,https://europepmc.org/articles/PMC5395742/,lung metastases,howing the number and volume of , in each group (n=6); **P<0. 01 ,TextQuoteSelector,TextPositionSelector,35385,35400,WT_DS,yes,[WT_DS][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T09:09:46.738642+00:00
mq1Tmq0nEem4WOfr9ABZwg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,Merlin,n. A previous study showed that , activates Hippo kinase signalin,TextQuoteSelector,TextPositionSelector,54663,54669,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:55:21.840266+00:00
m9zRsK0cEemsiIO-qPDOvQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,Hepatocellular carcinoma," LATS1, pYAPS127Go to:Background", (HCC) is one of the most common,TextQuoteSelector,TextPositionSelector,12569,12593,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:36:39.480443+00:00
loeqiLQ8EemStjs4ZHorTQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1,A novel lncRNA uc.134 represses ,"Wen Ni,1 Yuqin Zhang,1 Zetao Zha",TextQuoteSelector,TextPositionSelector,7041,7130,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:13:12.422447+00:00
jQkJUK0nEemZgjfPCTHm6A,b53nbDmi,https://europepmc.org/articles/PMC5395742/,MEK,ncreases resistance to RAF- and ,-targeted cancer therapies [41].,TextQuoteSelector,TextPositionSelector,54411,54414,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:54:58.890227+00:00
j3gygK0lEemJOF9LG81ZQA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,E3 ligase,ctivity [37]. Since CUL4A is an , that targets LATS1 protein for ,TextQuoteSelector,TextPositionSelector,42084,42093,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:40:43.987917+00:00
gY3dwK0eEeml0PtvbqE0KQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,Dlx-2,ty by directly interacting with , in a target- and homeodomain-sp,TextQuoteSelector,TextPositionSelector,14528,14533,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:50:14.293493+00:00
gTcMaq0pEemZRtcHuk2w4g,b53nbDmi,https://europepmc.org/articles/PMC5395742/,HOXA11,by qRT-PCR in HCC cells. (A) nc-,-86 (B) ENST00000426547 (C) ENST,TextQuoteSelector,TextPositionSelector,61273,61279,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T09:08:58.175472+00:00
fo1w3q0gEemabyeMVrMg1Q,b53nbDmi,https://europepmc.org/articles/PMC5395742/,cullin,he 400–671 aa region encoding a , homolog was cloned into pcDNA3.,TextQuoteSelector,TextPositionSelector,25759,25765,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:04:28.291166+00:00
fb5kqK0eEemcGyOS7ArE6w,b53nbDmi,https://europepmc.org/articles/PMC5395742/,Dlx-6,ic region between the Dlx-5 and ," genes, activates transcriptiona",TextQuoteSelector,TextPositionSelector,14451,14456,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:50:07.999374+00:00
fPv3oK0kEema7V_m_5jyYQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,RNP,at uc.134 and CUL4A can form an , complex in vitro. Previous stud,TextQuoteSelector,TextPositionSelector,38053,38056,WT_GP,yes,[WT_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:33:03.666417+00:00
f3TXoK0jEemsos8C8bLeKw,b53nbDmi,https://europepmc.org/articles/PMC5395742/,nude mice, inoculated subcutaneously into ,", and the HCCLM3 cell line was e",TextQuoteSelector,TextPositionSelector,28523,28532,CRT_OG,yes,[CRT_OG][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:25:58.308082+00:00
eZhXWq0cEemSt_eiKVeYTg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,YAP,tination of LATS1 and increases ,S127 phosphorylation to silence ,TextQuoteSelector,TextPositionSelector,11753,11756,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:35:41.932400+00:00
eVIFlq0eEemrykO3PzeETA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,Dlx-5,e intergenic region between the ," and Dlx-6 genes, activates tran",TextQuoteSelector,TextPositionSelector,14441,14446,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:50:00.327386+00:00
dPoSLLRiEemXd2ddvtSkrg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,CUL4A,"lular carcinoma, LncRNA uc.134, ",", Ubiquitination, LATS1, pYAPS12",TextQuoteSelector,TextPositionSelector,12557,12562,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T13:44:17.037503+00:00
cWA1tK0kEemZnFfvrVFrdg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,E3 ubiquitin ligase, mass spectrometry detected the ," CUL4A, and subsequent Western b",TextQuoteSelector,TextPositionSelector,37650,37669,WS_GP,yes,[WS_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:32:44.179799+00:00
cQWu4q0jEemPg5Nim1p3DA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,CCK8,o assess data obtained from the , assays and tumor growth. Correl,TextQuoteSelector,TextPositionSelector,27825,27829,WT_GP,yes,[WT_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:25:34.119283+00:00
cOFacq0gEemTyuc3s1G23A,b53nbDmi,https://europepmc.org/articles/PMC5395742/,Myc,r pcDNA3.1(+) with a C-terminal , tag and translated a 87.7-kilod,TextQuoteSelector,TextPositionSelector,25492,25495,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:04:05.254076+00:00
aeqFkq0eEemlz6M2eneCPw,b53nbDmi,https://europepmc.org/articles/PMC5395742/,MEG3,"e degradation of NF90 [19], and ", is a predictive biomarker for m,TextQuoteSelector,TextPositionSelector,14136,14140,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:49:34.513010+00:00
aRT8oK0fEemZfA9UjhZ4UA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,HRP,on with horseradish peroxidase (,)-conjugated anti-DIG antibodies,TextQuoteSelector,TextPositionSelector,20058,20061,WT_GP,no,[WT_GP],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:56:42.729327+00:00
_Um9YLQ8Eem2w2P2vv1Mkg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,LATS1 and pYAPS127 are reduced in the HCC,ly show that the expressions of , tissues compared with the adjac,TextQuoteSelector,TextPositionSelector,50430,50471,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:16:04.985669+00:00
Yjo-lq0eEemTxxOxXpAoDg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,NF90,tastases via the degradation of ," [19], and MEG3 is a predictive ",TextQuoteSelector,TextPositionSelector,14121,14125,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:49:21.682844+00:00
YPG1Yq0gEemPeksNPHgy9w,b53nbDmi,https://europepmc.org/articles/PMC5395742/,streptavidin,otinylated RNAs were mixed with , agarose beads (Life Technologie,TextQuoteSelector,TextPositionSelector,24881,24893,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:03:38.628117+00:00
XpPrGK0cEemJI9c91H93-w,b53nbDmi,https://europepmc.org/articles/PMC5395742/,polymerase,ISH) and quantitative real-time , chain reaction (qRT-PCR) analys,TextQuoteSelector,TextPositionSelector,10539,10549,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:34:56.707578+00:00
XgVOIK0nEem6lxPaIQgeZQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,RAF,hat YAP increases resistance to ,- and MEK-targeted cancer therap,TextQuoteSelector,TextPositionSelector,54402,54405,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:53:40.065350+00:00
WaP6xK0jEem2li918MhzjQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,protein A,ith the indicated antibodies on ,/G beads (Life Technologies) ove,TextQuoteSelector,TextPositionSelector,27127,27136,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:24:54.714662+00:00
WXDHEq0eEem-2BPevM2enQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,UFC1,"antation [16, 17]. Furthermore, ", promotes HCC cell proliferation,TextQuoteSelector,TextPositionSelector,13884,13888,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:49:06.877530+00:00
WWdrHK0fEem4NzvGxjDRpA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,peroxidase, by incubation with horseradish , (HRP)-conjugated anti-DIG antib,TextQuoteSelector,TextPositionSelector,20046,20056,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:56:16.422937+00:00
WUx75q0oEemZp1dJnZbv2g,b53nbDmi,https://europepmc.org/articles/PMC5395742/,hepatitis C virus infection,"virus (HBV) infection, although ", and exposure to toxic chemical ,TextQuoteSelector,TextPositionSelector,58476,58503,"WT_OG,DS",no,[WT_OG][DS],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T09:00:41.675661+00:00
V5EYYq0nEemsumMIso4f_A,b53nbDmi,https://europepmc.org/articles/PMC5395742/,Stat,", PI3-kinase/AKT, Hedgehog, Jak/",", and Notch pathways [40]. A pre",TextQuoteSelector,TextPositionSelector,54311,54315,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:53:29.233601+00:00
V0VW_q0gEeml4fMKr-_UXA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,DNase I,nd then treated with RNase-free , (Roche) and 0.2 M EDTA to stop ,TextQuoteSelector,TextPositionSelector,24794,24801,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:03:22.379910+00:00
Uw4Ciq0fEemomGvh1rLWRg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,horseradish,was detected by incubation with , peroxidase (HRP)-conjugated ant,TextQuoteSelector,TextPositionSelector,20034,20045,CRT_OG,no,CRT_OG,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:56:05.746154+00:00
UQ4Q_K0jEem39jO61QiF2g,b53nbDmi,https://europepmc.org/articles/PMC5395742/,Ubiquitin,on (IP) and ubiquitination assay,", LATS1, and uc.134 plasmids wer",TextQuoteSelector,TextPositionSelector,26841,26850,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:24:40.280101+00:00
UIH0_q0kEemZmsPdcEXFAg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,KI67,"expressing uc.134, the level of ", expression was lower than that ,TextQuoteSelector,TextPositionSelector,36160,36164,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:31:48.980829+00:00
UH_z7q0eEemXRT_0F1Gxcg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,tumor,"over, MALAT1 is associated with ", metastasis and can predict recu,TextQuoteSelector,TextPositionSelector,13789,13794,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:48:52.062131+00:00
TaSEbK0gEemslgOtLJ35zg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,T7 RNA polymerase ,in RNA Labeling Mix (Roche) and ,(Roche) and then treated with RN,TextQuoteSelector,TextPositionSelector,24735,24753,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:03:06.226622+00:00
TUDkWq0nEem4CG_RE2o4KA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,Notch,"se/AKT, Hedgehog, Jak/Stat, and ", pathways [40]. A previous study,TextQuoteSelector,TextPositionSelector,54321,54326,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:53:12.039440+00:00
SEK2PK0cEem4MdeTM5Mahg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,Hippo kinase,body of evidence indicates that , signaling is inactivated in man,TextQuoteSelector,TextPositionSelector,10072,10084,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:34:19.134417+00:00
S1HY4K0lEem3_VegM3SYTA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,RNA polymerase,ed ubiquitin protein ligase and , activity compared with the nega,TextQuoteSelector,TextPositionSelector,41736,41750,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:38:49.709736+00:00
RGFTtK0eEemxmv_wjwdprQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,MALAT1,"d metastasis [13–15]. Moreover, ", is associated with tumor metast,TextQuoteSelector,TextPositionSelector,13763,13769,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:48:31.638691+00:00
QnsHTq0nEem-9OvDyn__DA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,Hedgehog," WNT/β-catenin, PI3-kinase/AKT, ",", Jak/Stat, and Notch pathways [",TextQuoteSelector,TextPositionSelector,54297,54305,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:52:53.908932+00:00
PtNLjq0mEem98pN-oHkJqQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,polyubiquitin,eus to the cytoplasm to disrupt ," chains, which activates the Hip",TextQuoteSelector,TextPositionSelector,46482,46495,WT_GP,no,[WT_GP],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:45:38.143762+00:00
PO4nirQ9Eemz6uM4itix6w,b53nbDmi,https://europepmc.org/articles/PMC5395742/,LATS1 and pYAPS127 were significantly depressed in tumors,d that the expression levels of , compared with adjacent tissues.,TextQuoteSelector,TextPositionSelector,63446,63503,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:17:51.479779+00:00
OzAR-K0kEemv7L9qJ1vUBA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,tumors,001. e Representative images of , formed in nude mice (n=6). *P<0,TextQuoteSelector,TextPositionSelector,35209,35215,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:31:13.162246+00:00
O_ACUK0gEeml0xu8afftLQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,IgG,nput controls and normal rabbit , controls were assayed simultane,TextQuoteSelector,TextPositionSelector,24491,24494,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:02:36.402263+00:00
OQZkDK0cEemZe5u8U8Vf8Q,b53nbDmi,https://europepmc.org/articles/PMC5395742/,cancers,ignaling is inactivated in many ,". However, the upstream lncRNA r",TextQuoteSelector,TextPositionSelector,10118,10125,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:33:53.485995+00:00
OFVpbK0nEemstyP9cT9pHg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,AKT,"SMAD, WNT/β-catenin, PI3-kinase/",", Hedgehog, Jak/Stat, and Notch ",TextQuoteSelector,TextPositionSelector,54292,54295,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:52:37.008486+00:00
O9B25K0eEemolb_MwD7p0g,b53nbDmi,https://europepmc.org/articles/PMC5395742/,hepatocarcinogenesis ,ression plays critical roles in ,and metastasis [13–15]. Moreover,TextQuoteSelector,TextPositionSelector,13708,13729,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:48:17.264109+00:00
NSZePq0pEemqeiv8TzTxaQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,LATS1,UL4A-mediated ubiquitination of ,. Hippo kinase signaling is high,TextQuoteSelector,TextPositionSelector,59184,59189,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T09:06:50.542313+00:00
NFtSGq0gEemslZ_gwt0P3A,b53nbDmi,https://europepmc.org/articles/PMC5395742/,rabbit,-PCR. Input controls and normal , IgG controls were assayed simul,TextQuoteSelector,TextPositionSelector,24484,24490,CRT_OG,yes,[CRT_OG][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:02:23.681427+00:00
N7WZnLQ9EemsgTMReZizPQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,LATS1 and pYAPS127 expression levels in HCC,panels: HE staining. Figure S7. ," specimens. (A, B) IHC analysis ",TextQuoteSelector,TextPositionSelector,63301,63344,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:17:42.887633+00:00
MWyVEq0nEemQjMPwWQqeCg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,PI3-kinase,"s the TGFβ/SMAD, WNT/β-catenin, ","/AKT, Hedgehog, Jak/Stat, and No",TextQuoteSelector,TextPositionSelector,54281,54291,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:52:25.325661+00:00
LyZtnK0cEem36ksSFE_ZGQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,tumor,"mon malignancies worldwide, and ", recurrence and metastasis are m,TextQuoteSelector,TextPositionSelector,9833,9838,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:33:37.126019+00:00
Lupq9LQ9Eema6KcpVIWGVg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,"CUL4A, suggesting that it may serve as a tumor suppressor and prognostic biomarker in HCC",po kinase signaling by blocking ,".Go to:Additional files
Addition",TextQuoteSelector,TextPositionSelector,60631,60720,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:17:28.151980+00:00
KzKcgq0nEemosKNtsF-lLg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,β-catenin,"ays, such as the TGFβ/SMAD, WNT/",", PI3-kinase/AKT, Hedgehog, Jak/",TextQuoteSelector,TextPositionSelector,54270,54279,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:52:14.737230+00:00
KdHJiK0kEemr2Ct21-6Fgg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,cell invasion,tion of uc.134 markedly reduced , compared with control cells (Fi,TextQuoteSelector,TextPositionSelector,33969,33982,WT_DS,yes,[WT_DS][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:30:44.173778+00:00
KX5_Kq0gEemSwf-fNSd99g,b53nbDmi,https://europepmc.org/articles/PMC5395742/,RNase,protease inhibitor cocktail and , inhibitor were incubated on ice,TextQuoteSelector,TextPositionSelector,24067,24072,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:02:05.502342+00:00
JuOyjrQ9EemwMzO-63M_Vw,b53nbDmi,https://europepmc.org/articles/PMC5395742/,HCC by inhibiting CUL4A-mediated ubiquitination of LATS1,4 suppressed the progression of ,. Hippo kinase signaling is high,TextQuoteSelector,TextPositionSelector,59174,59230,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:17:14.558583+00:00
J2uhdq0mEem2qPOPCMADVA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,E2F1,"tor of apoptosis 1 (diap1), and ",", were significantly reduced. In",TextQuoteSelector,TextPositionSelector,45295,45299,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:44:59.028661+00:00
IpX_EK0nEemstRdn04isHg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,WNT,"athways, such as the TGFβ/SMAD, ","/β-catenin, PI3-kinase/AKT, Hedg",TextQuoteSelector,TextPositionSelector,54266,54269,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:52:00.507440+00:00
IfTZ8q0gEemQeOudPPDkdA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,protease,ed in lysis buffer containing a , inhibitor cocktail and RNase in,TextQuoteSelector,TextPositionSelector,24035,24043,WS_GP,no,WS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:01:52.875979+00:00
IYkyCq0cEemYUcNrSBz9qA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,malignancies,(HCC) is one of the most common ," worldwide, and tumor recurrence",TextQuoteSelector,TextPositionSelector,9805,9817,WT_DS,yes,[WT_DS][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:33:14.286874+00:00
IXvXXrQ9Eem8xz8-tNAu3w,b53nbDmi,https://europepmc.org/articles/PMC5395742/,LATS1 in HCC,of lncRNAs in the regulation of ,". Thus, this lncRNA may offer a ",TextQuoteSelector,TextPositionSelector,58259,58271,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:17:05.469482+00:00
IPWKEK0lEemv808xbzeaNA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,ubiquitin protein ligase, uc.134 significantly repressed , and RNA polymerase activity com,TextQuoteSelector,TextPositionSelector,41707,41731,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:37:38.679466+00:00
HjlyLK0mEem4TtsH5zKUHA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,diap1,phila inhibitor of apoptosis 1 (,"), and E2F1, were significantly ",TextQuoteSelector,TextPositionSelector,45283,45288,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:44:43.365960+00:00
Hj6Tlq0nEemZ3HN3L5UZFg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,SMAD,"ling pathways, such as the TGFβ/",", WNT/β-catenin, PI3-kinase/AKT,",TextQuoteSelector,TextPositionSelector,54260,54264,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:51:53.018238+00:00
HTrZzK0oEemS2kcNpsdb8w,b53nbDmi,https://europepmc.org/articles/PMC5395742/,caspases, directly binds to and inhibits , to suppress apoptosis. Activati,TextQuoteSelector,TextPositionSelector,56937,56945,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:59:00.790948+00:00
HP-CrLQ9Eemidlf_DW4NBA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,"HCC cells with plasmids expressing YAP and those expressing uc.134, the decrease in the mRNA level of CYR61, c-Myc, diap1, and E2F1","ion, when we co-transfected the "," was reversed by YAP, indicating",TextQuoteSelector,TextPositionSelector,57582,57713,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:16:57.945513+00:00
H4k6Vq0kEemXUFOE2YDwYA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,EGFP,at the stable overexpression of ,-LV-uc.134 (Additional file 5: F,TextQuoteSelector,TextPositionSelector,33631,33635,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:30:26.832732+00:00
GIsY9K0gEemrz9O9vRhnWQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,RNA-Binding Protein,s performed using the Magna RIP , Immunoprecipitation Kit (Millip,TextQuoteSelector,TextPositionSelector,23857,23876,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:01:37.053377+00:00
GIV87q0nEemS1jtonnSe-g,b53nbDmi,https://europepmc.org/articles/PMC5395742/,TGFβ,"signaling pathways, such as the ","/SMAD, WNT/β-catenin, PI3-kinase",TextQuoteSelector,TextPositionSelector,54255,54259,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:51:43.531147+00:00
GBBcHLQ9Eem8spc3GRfirg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,"E2F1, which plays key roles in cell cycle progression and cell differentiation in HCC",ion of the cell cycle regulator ," [48, 49]. We performed microarr",TextQuoteSelector,TextPositionSelector,57301,57386,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:16:49.545442+00:00
FzW0wq0cEem5wYsZ19ay-A,b53nbDmi,https://europepmc.org/articles/PMC5395742/,HCC,groundHepatocellular carcinoma (,) is one of the most common mali,TextQuoteSelector,TextPositionSelector,9774,9777,"WT_GP,DS",yes,[WT_GP][DS][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:32:56.747252+00:00
FmONgK0mEemodpuYDRLkgw,b53nbDmi,https://europepmc.org/articles/PMC5395742/,drosophila inhibitor of apoptosis 1,"enic inducer 61 (CYR61), c-Myc, "," (diap1), and E2F1, were signifi",TextQuoteSelector,TextPositionSelector,45246,45281,WS_GP,no,WS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:44:30.450357+00:00
FRxvsq0oEemwYCMnzZg-7Q,b53nbDmi,https://europepmc.org/articles/PMC5395742/,c-Abl,y of c-Myc via interaction with , in HCC [45]. diap1 directly bin,TextQuoteSelector,TextPositionSelector,56881,56886,WS_GP,no,WS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:58:47.346243+00:00
FInAVrQ9EemlD5NmlogeyA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,Myc via interaction with c-Abl in HCC,e transcriptional activity of c-, [45]. diap1 directly binds to a,TextQuoteSelector,TextPositionSelector,56897,56934,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:16:43.764053+00:00
EDhqxq0qEemRxYtVtS8lzQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,pepsin,", HCC samples were treated with ", for 10 min at room temperature ,TextQuoteSelector,TextPositionSelector,19277,19283,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T09:12:57.977029+00:00
DixaEK0nEema9E8x2fJfjA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,tumor,"ignaling, which is critical for "," progression and invasion, is in",TextQuoteSelector,TextPositionSelector,54019,54024,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:51:26.218395+00:00
DNU4pLQ9Eem33lt23MLERQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,LATS1/2 in NF2-mutant tumors,y binding to and ubiquitinating ," in the nucleus [37]. However, t",TextQuoteSelector,TextPositionSelector,55213,55241,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:16:31.056224+00:00
DBdGzq0gEemPguvkJHsNnw,b53nbDmi,https://europepmc.org/articles/PMC5395742/,β-actin,plified as an internal control. , and U6 were used as cytoplasmic,TextQuoteSelector,TextPositionSelector,23589,23596,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:01:16.171084+00:00
D2wwXq0mEem2m8vG8_kUgQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,c-Myc," angiogenic inducer 61 (CYR61), ",", drosophila inhibitor of apopto",TextQuoteSelector,TextPositionSelector,45239,45244,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:44:18.580289+00:00
Cif7qK0oEeml8EdjjfcQLg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,glioblastoma,ed the invasive activity of the , cells [44]. Inactivation of c-M,TextQuoteSelector,TextPositionSelector,56668,56680,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:58:28.894303+00:00
CMLWaLQ9EemzfBPw6nYaew,b53nbDmi,https://europepmc.org/articles/PMC5395742/,LATS1 is a core kinase of Hippo kinase signaling pathway and plays important roles in tumor,"er, the serine/threonine kinase "," proliferation, apoptosis, and s",TextQuoteSelector,TextPositionSelector,54526,54617,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:16:23.964190+00:00
CKNSSK0mEemZkpN8muKcHw,b53nbDmi,https://europepmc.org/articles/PMC5395742/,CYR61,ine-rich angiogenic inducer 61 (,"), c-Myc, drosophila inhibitor o",TextQuoteSelector,TextPositionSelector,45231,45236,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:44:07.468374+00:00
BRWswK0cEemJIrvVCHnjeg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,LATS1,UL4A-mediated ubiquitination of ,"Wen Ni,1 Yuqin Zhang,1 Zetao Zha",TextQuoteSelector,TextPositionSelector,7084,7089,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:32:26.563769+00:00
B4hyhq0lEemqau-iPLHb5g,b53nbDmi,https://europepmc.org/articles/PMC5395742/,colon cancer,A to promote the development of , [33]. Although CUL4A is predomi,TextQuoteSelector,TextPositionSelector,40771,40783,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:36:55.819191+00:00
AvCHWLQ9EemmU6O0Knle7g,b53nbDmi,https://europepmc.org/articles/PMC5395742/,CUL4A-Hippo axis may offer a promising approach for the treatment of HCC,"naling. Thus, the lncRNA uc.134-"," (Fig. 6e).
Go to:DiscussionHCC ",TextQuoteSelector,TextPositionSelector,51192,51264,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:16:13.980116+00:00
AcWObK0oEem2r_ufAJwILQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,vascularization,be involved in tumor growth and ,. Previous reports showed that t,TextQuoteSelector,TextPositionSelector,56545,56560,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:58:14.652438+00:00
A65FHq0gEemxnaPCYuaOhA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,GAPDH,ucibility of the results. Human , gene was amplified as an intern,TextQuoteSelector,TextPositionSelector,23540,23545,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:01:01.893139+00:00
A06pIK0pEemiV4eYQZgZFw,b53nbDmi,https://europepmc.org/articles/PMC5395742/,HBV infection,c.134 in HCC may be mediated by ," at the transcriptional level, p",TextQuoteSelector,TextPositionSelector,58885,58898,"WT_OG,DS",no,[WT_OG][DS],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T09:05:26.721321+00:00
9yL4ILQ8Eem__sv5bqxDGg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,HCC patients with low LATS1,The median survival time of the ," expression was 16 months, which",TextQuoteSelector,TextPositionSelector,49641,49668,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:15:54.680537+00:00
9leKgK0nEemRvF_tGEZMLg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,TEAD,"transcription, YAP binds to the ", complex and elevates the levels,TextQuoteSelector,TextPositionSelector,56337,56341,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:57:55.687892+00:00
9ktF1K0pEemZjlNBD09ZwQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,CRL4,", an E3 ubiquitin ligase of the ", complex [42]. CUL4A is a core c,TextQuoteSelector,TextPositionSelector,54758,54762,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T09:12:14.457978+00:00
9RgsAK0oEemcMovoSAMjnw,b53nbDmi,https://europepmc.org/articles/PMC5395742/,HDAC3,CC [20]. Histone deacetylase 3 (,) is involved in the suppression,TextQuoteSelector,TextPositionSelector,58748,58753,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T09:05:03.185333+00:00
9DOrLq0kEem2o0trShDx7g,b53nbDmi,https://europepmc.org/articles/PMC5395742/,DICER1, triggers the ubiquitination of , in cytoplasm by CUL4A to promot,TextQuoteSelector,TextPositionSelector,40712,40718,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:36:23.690765+00:00
8hDQvrQ8Eem8HmusUYLwEA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,LATS1 was significantly downregulated in the tumor,ang Hospital. The expression of , tissues compared with the adjac,TextQuoteSelector,TextPositionSelector,49322,49372,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:15:45.831459+00:00
8GbH1K0jEem6jKuGZbkxvg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,Tumor,)3.8850.037 <25674225 ≥251037924, size (cm)0.0420.487 <51138132 ≥,TextQuoteSelector,TextPositionSelector,32415,32420,MIS_DIS,yes,[MIS_DIS][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:29:07.447822+00:00
7ibYiK0oEemiVtM6cbl2ZA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,Histone deacetylase 3,utes to the growth of HCC [20]. , (HDAC3) is involved in the supp,TextQuoteSelector,TextPositionSelector,58725,58746,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T09:04:51.531192+00:00
7VsbJK0lEeml5k8skiSa5Q,b53nbDmi,https://europepmc.org/articles/PMC5395742/,MST1,"ignaling pathway, such as Mob1, ","/2, LATS1, and YAP, whereas the ",TextQuoteSelector,TextPositionSelector,45117,45121,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:43:21.633417+00:00
7SNPyLQ8EemaIX9nIXJeUw,b53nbDmi,https://europepmc.org/articles/PMC5395742/,LATS1 or pYAPS127 in 90 paraffin-embedded surgical specimens of HCC, to determine the expression of , from Nanfang Hospital. The expr,TextQuoteSelector,TextPositionSelector,49213,49280,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:15:37.653640+00:00
6mbHmK0fEemZI9NnH7ZUUA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,reverse transcriptase,total RNA was performed using a , cDNA synthesis kit (Takara). Th,TextQuoteSelector,TextPositionSelector,23059,23080,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:00:19.635369+00:00
6j9lrq0pEem55-f6ZKa16w,b53nbDmi,https://europepmc.org/articles/PMC5395742/,tumorigenesis, uc.134-mediated changes in the , genes are dependent on YAP. The,TextQuoteSelector,TextPositionSelector,45433,45446,WT_DS,yes,[WT_DS][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T09:11:54.070423+00:00
6X6iRq0lEemssD_DXmm1mw,b53nbDmi,https://europepmc.org/articles/PMC5395742/,Mob1,"ippo signaling pathway, such as ",", MST1/2, LATS1, and YAP, wherea",TextQuoteSelector,TextPositionSelector,45111,45115,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:43:15.195129+00:00
5zNMEK0dEem9zhOlFgAxSA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,cancer,ne of the most common causes of ," mortality worldwide [1, 2]. Cur",TextQuoteSelector,TextPositionSelector,12636,12642,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:45:55.054354+00:00
5wGSErQ8EemsgCe5wnmYvg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,"LATS1, and pYAPS127 expression by ISH and IHC in paraffin-embedded samples from patients with HCC ","died correlations among uc.134, ",(Fig. 6a). IHC analysis was used,TextQuoteSelector,TextPositionSelector,49051,49149,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:15:27.370653+00:00
58p6TK0bEemXQzPRbFWv_g,b53nbDmi,https://europepmc.org/articles/PMC5395742/,hepatocellular carcinoma,A novel lncRNA uc.134 represses , progression by inhibiting CUL4A,TextQuoteSelector,TextPositionSelector,7000,7024,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:31:37.362986+00:00
4k3MzLQ8Eem8Hacd_QUgAA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,LATS1 and pYAPS127 levels in HCC,sion positively correlates with , patient samplesWe studied corre,TextQuoteSelector,TextPositionSelector,48965,48997,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:15:19.440192+00:00
43bDoq0kEemr3kMgSOrFLg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,STAT3,n that inflammation-induced Jak-, signaling triggers the ubiquiti,TextQuoteSelector,TextPositionSelector,40665,40670,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:35:55.559454+00:00
3akKjq0kEemiSrdVXypuZQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,Jak,shown that inflammation-induced ,-STAT3 signaling triggers the ub,TextQuoteSelector,TextPositionSelector,40661,40664,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:35:45.616024+00:00
3FDfxrQ8EemqaXfspnmZ9A,b53nbDmi,https://europepmc.org/articles/PMC5395742/,HCC by blocking CUL4A nuclear export to ubiquitinate LATS1,"on, invasion, and metastasis of ", and increasing YAPS127 phosphor,TextQuoteSelector,TextPositionSelector,47747,47805,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:15:09.468733+00:00
2qD2eK0dEemKy4tD92IT2g,b53nbDmi,https://europepmc.org/articles/PMC5395742/,HCC,groundHepatocellular carcinoma (,) is one of the most common caus,TextQuoteSelector,TextPositionSelector,12595,12598,MIS_DS,yes,[MIS_DS][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:45:34.291272+00:00
2Z31UK0nEemXYduRYF56Qg,b53nbDmi,https://europepmc.org/articles/PMC5395742/,cancer,te many important activities in , through their interactions with,TextQuoteSelector,TextPositionSelector,55877,55883,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:57:07.585967+00:00
2DJEOq0fEem2hN-rVvPHXQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,lung metastasis,araffin for ISH or IHC. For the ," model, 2×106 cells were injecte",TextQuoteSelector,TextPositionSelector,21881,21896,WT_DS,yes,[WT_DS][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:59:49.106553+00:00
1WhcGK0eEemQc1ONoRQYEw,b53nbDmi,https://europepmc.org/articles/PMC5395742/,serine/threonine-protein kinase LATS1,"is. By phosphorylating YAP, the ", inhibits the translocation of Y,TextQuoteSelector,TextPositionSelector,15131,15168,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:52:35.041572+00:00
1Umsrq0kEemoW1OYz8GHbA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,DICER," CUL4A including p53, p21, p27, ",", and LATS1 [32]. Previous studi",TextQuoteSelector,TextPositionSelector,40584,40589,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:35:31.759466+00:00
15k2DrQ8Eem8sS8M6RgHzQ,b53nbDmi,https://europepmc.org/articles/PMC5395742/,CUL4A overexpression abrogated the uc.134-mediated repression HCC,l function analysis showed that , cell proliferation and invasion,TextQuoteSelector,TextPositionSelector,47446,47511,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:15:01.785011+00:00
0wuT4q0mEemZmX83V16F0g,b53nbDmi,https://europepmc.org/articles/PMC5395742/,carcinomas,and differentially expressed in ,". Here, we used lncRNA microarra",TextQuoteSelector,TextPositionSelector,51942,51952,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:49:46.942482+00:00
0ckF2LQ8EemwMsPrgx5-aw,b53nbDmi,https://europepmc.org/articles/PMC5395742/,CUL4A to overcome the uc.134-mediated activation of Hippo kinase signaling in HCC,We then assessed the ability of ," cells. Notably, Western blottin",TextQuoteSelector,TextPositionSelector,47000,47081,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T09:14:51.743003+00:00
0-qbWK0oEemxtNu2uvcAzA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,hepatitis B virus (HBV) infection,risk factor for HCC in China is ,", although hepatitis C virus inf",TextQuoteSelector,TextPositionSelector,58432,58465,"WT_OG,DS",no,[WT_OG][DS],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T09:04:07.180957+00:00
-qSfnq0bEem9ygMA-uCrCA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,CUL4A,inoma progression by inhibiting ,-mediated ubiquitination of LATS,TextQuoteSelector,TextPositionSelector,7051,7056,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:32:08.916881+00:00
-fRuKK0jEem3-RP0Eylj0Q,b53nbDmi,https://europepmc.org/articles/PMC5395742/,AFP,tive483414 Positive1198435Serum , (ng/ml)3.8850.037 <25674225 ≥25,TextQuoteSelector,TextPositionSelector,32373,32376,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:29:23.761228+00:00
-dM93q0eEemKzePD8DDTNA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,human,", Rockville, MD). The Arraystar ", lncRNA microarray is designed f,TextQuoteSelector,TextPositionSelector,17156,17161,CRT_OG,yes,[CRT_OG][ALL],,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T07:53:36.131142+00:00
-N0Ndq0mEemnfgcKU_1pXw,b53nbDmi,https://europepmc.org/articles/PMC5395742/,mammals,naling pathway are conserved in , and have a complex network of c,TextQuoteSelector,TextPositionSelector,54154,54161,CRT_OG,no,CRT_OG,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:50:50.407626+00:00
-97fAK0lEemZkWf6j1qAhA,b53nbDmi,https://europepmc.org/articles/PMC5395742/,cysteine-rich angiogenic inducer 61,"ls of YAP target genes, such as "," (CYR61), c-Myc, drosophila inhi",TextQuoteSelector,TextPositionSelector,45194,45229,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T08:43:46.016356+00:00
